|
1
|
Mattiuzzi C and Lippi G: Current cancer
epidemiology. J Epidemiol Glob Health. 9:217–222. 2019.PubMed/NCBI View Article : Google Scholar
|
|
2
|
D'Amico AV, Whittington R, Malkowicz SB,
Schultz D, Blank K, Broderick GA, Tomaszewski JE, Renshaw AA,
Kaplan I, Beard CJ and Wein A: Biochemical outcome after radical
prostatectomy, external beam radiation therapy, or interstitial
radiation therapy for clinically localized prostate cancer. JAMA.
280:969–974. 1998.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Burke HB: Predicting clinical outcomes
using molecular biomarkers. Biomark Cancer. 8:89–99.
2016.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Milicevic N, Mrcela M, Galic J and
Marjanovic K: Expression of proinflammatory cytokine interleukin-6
in tissue samples of human prostate obtained by needle biopsy.
Pathol Res Pract. 211:865–870. 2015.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Ma D, Zhou Z, Yang B, He Q, Zhang Q and
Zhang XH: Association of molecular biomarkers expression with
biochemical recurrence in prostate cancer through tissue microarray
immunostaining. Oncol Lett. 10:2185–2191. 2015.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Rodriguez-Berriguete G, Sanchez-Espiridion
B, Cansino JR, Olmedilla G, Martinez-Onsurbe P, Sanchez-Chapado M,
Paniagua R, Fraile B and Royuela M: Clinical significance of both
tumor and stromal expression of components of the IL-1 and TNF-α
signaling pathways in prostate cancer. Cytokine. 64:555–563.
2013.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Deorukhkar A and Krishnan S: Targeting
inflammatory pathways for tumor radiosensitization. Biochem
Pharmacol. 80:1904–1914. 2010.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Steiner GE, Newman ME, Paikl D, Stix U,
Memaran-Dagda N, Lee C and Marberger MJ: Expression and function of
pro-inflammatory interleukin IL-17 and IL-17 receptor in normal,
benign hyperplastic, and malignant prostate. Prostate. 56:171–182.
2003.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Poutahidis T, Rao VP, Olipitz W, Taylor
CL, Jackson EA, Levkovich T, Lee CW, Fox JG, Ge Z and Erdman SE:
CD4+ lymphocytes modulate prostate cancer progression in
mice. Int J Cancer. 125:868–878. 2009.PubMed/NCBI View Article : Google Scholar
|
|
10
|
George DJ, Halabi S, Shepard TF, Sanford
B, Vogelzang NJ, Small EJ and Kantoff PW: The prognostic
significance of plasma interleukin-6 levels in patients with
metastatic hormone-refractory prostate cancer: Results from cancer
and leukemia group B 9480. Clin Cancer Res. 11:1815–1820.
2005.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Rubin P, Johnston CJ, Williams JP,
McDonald S and Finkelstein JN: A perpetual cascade of cytokines
postirradiation leads to pulmonary fibrosis. Int J Radiat Oncol
Biol Phys. 33:99–109. 1995.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Christensen E, Pintilie M, Evans KR,
Lenarduzzi M, Menard C, Catton CN, Diamandis EP and Bristow RG:
Longitudinal cytokine expression during IMRT for prostate cancer
and acute treatment toxicity. Clin Cancer Res. 15:5576–83.
2009.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Hoogland AM, Kweldam CF and van Leenders
GJ: Prognostic histopathological and molecular markers on prostate
cancer needle-biopsies: A review. Biomed Res Int.
2014(341324)2014.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Epstein JI, Allsbrook WC Jr, Amin MB and
Egevad LL: ISUP Grading Committee. The 2005 International society
of urological pathology (ISUP) consensus conference on gleason
grading of prostatic carcinoma. Am J Surg Pathol. 29:1228–1242.
2005.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Van der Kwast T, Bubendorf L, Mazerolles
C, Raspollini MR, Van Leenders GJ, Pihl CG and Kujala P: Guidelines
on processing and reporting of prostate biopsies: The 2013 update
of the pathology committee of the European randomized study of
screening for prostate cancer (ERSPC). Virchows Arch. 463:367–377.
2013.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Gleason DF: Histologic grading of prostate
cancer: A perspective. Hum Pathol. 23:273–279. 1992.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Tagai EK, Miller SM, Kutikov A, Diefenbach
MA, Gor RA, Al-Saleem T, Chen DYT, Fleszar S and Roy G: Prostate
cancer patients' understanding of the gleason scoring system:
Implications for shared decision-making. J Cancer Educ. 34:441–445.
2019.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Epstein JI, Feng Z, Trock BJ and
Pierorazio PM: Upgrading and downgrading of prostate cancer from
biopsy to radical prostatectomy: Incidence and predictive factors
using the modified Gleason grading system and factoring in tertiary
grades. Eur Urol. 61:1019–1024. 2012.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Zimmermann AK, Camenisch U, Rechsteiner
MP, Bode-Lesniewska B and Rossle M: Value of immunohistochemistry
in the detection of BRAF(V600E) mutations in fine-needle aspiration
biopsies of papillary thyroid carcinoma. Cancer Cytopathol.
122:48–58. 2014.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Kapoor P and Deshmukh R: VEGF: A critical
driver for angiogenesis and subsequent tumor growth: An IHC study.
J Oral Maxillofac Pathol. 16:330–337. 2012.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Wu YS, Wu XB, Zhang N, Jiang GL, Yu Y,
Tong SJ, Jiang HW, Mao SH, Na R and Ding Q: Evaluation of PSA-age
volume score in predicting prostate cancer in Chinese population.
Asian J Androl. 20:324–329. 2018.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Pessoa R, Werahera PN and Kim FJ: Chapter
102-Prostate Cancer. In Abernathy's Surgical Secrets, 7th edition.
Harken AH and Moore EE (eds). Elsevier, Philadelphia, PA,
pp450-451, 2018.
|
|
23
|
Kır G, Seneldir H and Gumus E: Outcomes of
Gleason score 3+4=7 prostate cancer with minimal amounts (<6%)
vs. ≥6% of Gleason pattern 4 tissue in needle biopsy specimens. Ann
Diagn Pathol. 20:48–51. 2016.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Freedland SJ and Moul JW: Prostate
specific antigen recurrence after definitive therapy. J Urol.
177:1985–1991. 2007.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Doganavsargil B, Simsir A, Boyacioglu H,
Cal C and Hekimgil M: A comparison of p21 and p27 immunoexpression
in benign glands, prostatic intraepithelial neoplasia and prostate
adenocarcinoma. BJU Int. 97:644–648. 2006.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Pfitzenmaier J, Vessella R, Higano CS,
Noteboom JL, Wallace D Jr and Corey E: Elevation of cytokine levels
in cachectic patients with prostate carcinoma. Cancer.
97:1211–1216. 2003.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Mauri D, Pentheroudakis G, Tolis C,
Chojnacka M and Pavlidis N: Inflammatory prostate cancer: An
underestimated paraneoplastic clinical manifestation. Urol Oncol.
23:318–322. 2005.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Romero Otero J, Garcia Gomez B, Campos
Juanatey F and Touijer KA: Prostate cancer biomarkers: An update.
Urol Oncol. 32:252–260. 2014.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Wu D, Ni J, Beretov J, Cozzi P, Willcox M,
Wasinger V, Walsh B, Graham P and Li Y: Urinary biomarkers in
prostate cancer detection and monitoring progression. Crit Rev
Oncol Hematol. 118:15–26. 2017.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Lilja H, Ulmert D and Vickers AJ:
Prostate-specific antigen and prostate cancer: Prediction,
detection and monitoring. Nat Rev Cancer. 8:268–278.
2008.PubMed/NCBI View
Article : Google Scholar
|
|
31
|
Nassif AE and Tambara Filho R:
Immunohistochemistry expression of tumor markers CD34 and P27 as a
prognostic factor of clinically localized prostate adenocarcinoma
after radical prostatectomy. Rev Col Bras Cir. 37:338–344.
2010.PubMed/NCBI View Article : Google Scholar : (In English,
Portuguese).
|
|
32
|
Shariat SF, Kattan MW, Traxel E, Andrews
B, Zhu K, Wheeler TM and Slawin KM: Association of pre- and
postoperative plasma levels of transforming growth factor beta(1)
and interleukin 6 and its soluble receptor with prostate cancer
progression. Clin Cancer Res. 10:1992–1999. 2004.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Cansino Alcaide JR, Vera San Martin R,
Rodriguez de Bethencourt Codes F, Bouraoui Y, Rodriguez Berriguete
G, Oueslati R, Perez-Utrilla M, De la Pena Barthel J, Paniagua
Gomez-Alvarez R and Royuela Garcia M: Prostatic specific antigen
(PS), pro-inflammatory cytokines, and prostatic pathology (benign
prostatic hyperplasia and cancer). Relationship with malignancy.
Arch Esp Urol. 62:359–366. 2009.PubMed/NCBI View Article : Google Scholar : (In Spanish).
|
|
34
|
Epstein JI: An update of the Gleason
grading system. J Urol. 183:433–440. 2010.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Shen MM and Abate-Shen C: Molecular
genetics of prostate cancer: New prospects for old challenges.
Genes Dev. 24:1967–2000. 2010.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Stock RG, Cesaretti JA, Hall SJ and Stone
NN: Outcomes for patients with high-grade prostate cancer treated
with a combination of brachytherapy, external beam radiotherapy and
hormonal therapy. BJU Int. 104:1631–1636. 2009.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Michalaki V, Syrigos K, Charles P and
Waxman J: Serum levels of IL-6 and TNF-alpha correlate with
clinicopathological features and patient survival in patients with
prostate cancer. Br J Cancer. 90:2312–2316. 2004.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Gomes IM, Arinto P, Lopes C, Santos CR and
Maia CJ: STEAP1 is overexpressed in prostate cancer and prostatic
intraepithelial neoplasia lesions, and it is positively associated
with Gleason score. Urol Oncol. 32:53.e23–29. 2014.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Rube CE, Palm J, Erren M, Fleckenstein J,
Konig J, Remberger K and Rube C: Cytokine plasma levels: reliable
predictors for radiation pneumonitis? PLoS One.
3(e2898)2008.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Singh J, Sohal SS, Ahuja K, Lim A, Duncan
H, Thachil T and De Ieso P: Levels of plasma cytokine in patients
undergoing neoadjuvant androgen deprivation therapy and external
beam radiation therapy for adenocarcinoma of the prostate. Ann
Transl Med. 8(636)2020.PubMed/NCBI View Article : Google Scholar
|
